To avoid these problems, we initially examined locally metastatic tumours (which should not contain non‐neoplastic myoepithelium) and found that 41% of ER+, PR+ or HER2+ cancers contained pan‐p63+ and ∆Np63/p40+ cells, but not TAp63+ cells. The gene discussed is ERBB2; the disease is cancer.